Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results> Sanofi 1Q Earnings and Revenue Beat Expectations
Recommend 2 Positive 1 Negative 2 |
||||
|
||||
|
Sanofi reported that first-quarter revenue increased 13.6% YoY at constant exchange rates to EUR10.509 billion, while EPS reached EUR1.88, both exceeding market expectations. During the quarter, revenue from blockbuster dermatology and asthma drug Dupixent maintained strong growth, surging 31% YoY to EUR4.2 billion. Sanofi reiterated its full-year guidance for high single-digit sales growth at constant exchange rates, with EPS growth expected to outpace sales growth. In addition, Belen Garijo will assume the role of Group Chief Executive Officer at the end of this month. (mn/j) This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
